المؤلفون: Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD

المصدر: JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100636- (2024)

مصطلحات موضوعية: Non–small cell lung cancer, Epidermal growth factor receptor, EGFR TKI, Osimertinib, Central nervous system, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364324000067; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/2ca2a2673ed6490287b76ea50654af86

المؤلفون: Hideki Ikeda, MD, Joji Nagasaki, MD, PhD, Daiki Shimizu, MD, Yuki Katsuya, MD, PhD, Hidehito Horinouchi, MD, PhD, Yukio Hosomi, MD, PhD, Etsuko Tanji, MS, Takekazu Iwata, MD, PhD, Makiko Itami, MD, PhD, Masahito Kawazu, MD, PhD, Yuichiro Ohe, MD, PhD, Takuji Suzuki, MD, PhD, Yosuke Togashi, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100573- (2023)

مصطلحات موضوعية: Thymic epithelial tumor, Cancer immunotherapy, CD80/CD86, MHC, Memory precursor effector T cell, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323001169; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/e22f91bb33b34c45b99ef4b5ba01a266

المؤلفون: Hitomi Jo, MD, PhD, Tatsuya Yoshida, MD, PhD, Shigehiro Yagishita, MD, PhD, Mayu Ohuchi, PhD, Yuji Matsumoto, MD, PhD, Yuki Shinno, MD, PhD, Yusuke Okuma, MD, PhD, Yasushi Goto, MD, PhD, Hidehito Horinouchi, MD, PhD, Noboru Yamamoto, MD, PhD, Kazuhisa Takahashi, MD, PhD, Noriko Motoi, MD, PhD, Akinobu Hamada, PhD, Yuichiro Ohe, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 4, Pp 100474- (2023)

مصطلحات موضوعية: Anti–PD-1 inhibitor, Non–small cell lung cancer, Long-term response, Pharmacokinetics, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323000139; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/fbc7fcbfc26745ea85440370d0442d63

المؤلفون: Marina C. Garassino, MD, Shirish Gadgeel, MD, Silvia Novello, MD, PhD, Balazs Halmos, MD, Enriqueta Felip, MD, Giovanna Speranza, MD, Rina Hui, PhD, Edward B. Garon, MD, Hidehito Horinouchi, MD, PhD, Shunichi Sugawara, MD, PhD, Delvys Rodriguez-Abreu, MD, PhD, Martin Reck, MD, Razvan Cristescu, PhD, Deepti Aurora-Garg, PhD, Andrey Loboda, PhD, Jared Lunceford, PhD, Julie Kobie, PhD, Mark Ayers, MS, Bilal Piperdi, MD, M. Catherine Pietanza, MD, Luis Paz-Ares, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100431- (2023)

مصطلحات موضوعية: Tissue tumor mutational burden, Single-gene genetic alterations, Pembrolizumab, Metastatic non‒small-cell lung cancer, Biomarker, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364322001552; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/5b31e33aa86a4148993ed9fca9e915ac

المؤلفون: Hideki Terai, MD, Kenzo Soejima, MD, Asanao Shimokawa, PhD, Hidehito Horinouchi, MD, Junichi Shimizu, MD, Tetsunari Hase, MD, Ryota Kanemaru, MD, Kana Watanabe, MD, Kiichiro Ninomiya, MD, Naoko Aragane, MD, Noriko Yanagitani, MD, Yoshihiko Sakata, MD, Masahiro Seike, MD, Daichi Fujimoto, MD, Masashi Kasajima, MD, Akihito Kubo, MD, Sojiro Kusumoto, MD, Yoshitaka Oyamada, MD, Keiichi Fujiwara, MD, Masahide Mori, MD, Midori Hashimoto, MD, Masato Shingyoji, MD, Masahiro Kodani, MD, Jin Sakamoto, MD, Toshihiko Agatsuma, MD, Kosuke Kashiwabara, MD, Minehiko Inomata, MD, Motoko Tachihara, MD, Kazuhisa Tanaka, MD, Kenji Hayashihara, MD, Nobuyuki Koyama, MD, Kaoru Matsui, MD, Koichi Minato, MD, Daisuke Jingu, MD, Hiroyuki Sakashita, MD, Satoshi Hara, MD, Tomoyuki Naito, MD, Asuka Okada, MD, Masayuki Tanahashi, MD, Yuki Sato, MD, Koichiro Asano, MD, Takayuki Takeda, MD, Kensuke Nakazawa, MD, Toshiyuki Harada, MD, Kazuhiko Shibata, MD, Tatsuo Kato, MD, Etsuo Miyaoka, PhD, Ichiro Yoshino, MD, Akihiko Gemma, MD, Tetsuya Mitsudomi, MD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 11, Pp 100404- (2022)

مصطلحات موضوعية: Real-world data, Pembrolizumab, Immune checkpoint inhibitor, Immune-related adverse events, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266636432200128X; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/67a827674fcd4c4087dafceff77375be

المؤلفون: Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100311- (2022)

مصطلحات موضوعية: Non–small cell lung cancer, Anaplastic lymphoma kinase, Lorlatinib, Chemotherapy, Pemetrexed, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364322000352; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/e34bc5fff85145d196a7f16895ceb314